Experience of pemetrexed in maintenance therapy for metastatic lung adenocarcinoma
Lung cancer is among the most common malignant diseases in Russia. In 80–90%, its morphological type is nonsmall cell lung cancer. Stage IV primary advanced lung cancer is diagnosed in 41% of patients. Median overall survival in stage IV patients receiving chemotherapy is 7–12 months. Treatment for...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Russo |
| I whakaputaina: |
ANO "Perspective of oncology"
2021-03-01
|
| Rangatū: | Южно-Российский онкологический журнал |
| Ngā marau: | |
| Urunga tuihono: | https://www.cancersp.com/jour/article/view/105 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|